{"id":"W2782500168","doi":"10.1182/blood.v130.suppl_1.651.651","title":"Nivolumab for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma (cHL): Results from the Phase 2 Checkmate 205 Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stage (stratigraphy); Medicine; Classical Hodgkin lymphoma; Internal medicine; Lymphoma; Phases of clinical research; Nivolumab; Oncology; Hodgkin lymphoma; Chemotherapy; Cancer; Biology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001759888,0.0003895205,0.0005780471,0.0001760156,0.0001956818,0.0006554358,0.0003811774,0.0004769756,0.001230509],"category_scores_gemma":[0.0008053945,0.0001690148,0.0008947158,0.0001919773,0.0002175735,0.0003705083,0.0002883265,0.0008836183,0.0002822767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008844985,"about_ca_system_score_gemma":0.0006970214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001326001,"about_ca_topic_score_gemma":0.005568103,"domain_scores_codex":[0.9996583,0.0001686752,0.00002188991,0.00005398514,0.00005045654,0.00004668319],"domain_scores_gemma":[0.9994873,0.000108812,0.0001122803,0.00004027785,0.00006373784,0.0001876161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4697426,0.01758567,0.1674105,0.003348096,0.008337537,0.0004302014,0.0003586503,0.004378118,0.03708866,0.000527041,0.02066012,0.2701329],"study_design_scores_gemma":[0.3141422,0.2013691,0.4285251,0.0005733951,0.009926973,0.001094904,0.0002395865,0.005221969,0.008533807,0.0006160857,0.02964244,0.0001144254],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882773,0.006689422,0.0002148429,0.0003575853,0.00008657604,0.0006794029,0.002147961,0.00003445788,0.001512429],"genre_scores_gemma":[0.9887714,0.002250697,0.0007110108,0.001342817,0.0000979446,0.0005403707,0.005496842,0.00001792093,0.0007710019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001759888,"threshold_uncertainty_score":0.009307265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03561818650001681,"score_gpt":0.3333252716212414,"score_spread":0.2977070851212246,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}